CPAP withdrawal on 24-hour blood pressure and arterial stiffness in women and men with obstructive sleep apnea. A randomized controlled trial
C Sahlin, A Blomberg, KA Franklin - Sleep Medicine, 2017
Materials and methods: One hundred CPAP treated patients with moderate and severe
sleep apnea were randomized to either withdrawal treatment for 5 days (n= 50) or to
continue with CPAP for 5 days (n= 50). 24-hours blood pressure, arterial stiffness measured
sleep apnea were randomized to either withdrawal treatment for 5 days (n= 50) or to
continue with CPAP for 5 days (n= 50). 24-hours blood pressure, arterial stiffness measured
 |  |  |
Insomnia severity and self-efficacy optimally predict adherence to CPAP in apneic patients
P Philip, E Altena, PJ Monteyrol, O Coste, K Guichard… - Sleep Medicine, 2017
Materials and methods: 404 subjects with OSAS diagnosed in the sleep clinic of Bordeaux
University Hospital treated by continuous positive airway pressure (CPAP) and followed by
Vitalaire home care received the Insomnia Severity Index (ISI) questionnaire and the French
University Hospital treated by continuous positive airway pressure (CPAP) and followed by
Vitalaire home care received the Insomnia Severity Index (ISI) questionnaire and the French
| | |
Effects of cpap therapy on blood pressure variability (BPV) in people with comorbid obstructive sleep apnoea (OSA) and cardiovascular disease (CVD): save trial
E Van Ryswyk, W Quan, R Meng, Q Li, C Anderson… - Sleep Medicine, 2017
Materials and methods: The SAVE study was an international, multi-centre, randomised,
parallel group, open-label trial in which patients with moderate-severe OSA and established
cardiac or cerebral CVD were randomised to CPAP or usual care. This sub-analysis
parallel group, open-label trial in which patients with moderate-severe OSA and established
cardiac or cerebral CVD were randomised to CPAP or usual care. This sub-analysis
| | |
Simple telemedicine intervention to improve CPAP compliance on OSA patients to minimal (> 4 h) and optimal (> 5.5 h) use: study design (CPAP-rescue)
MC Suarez, O Garmendia, VM Lugo, A Moraleda… - Sleep Medicine, 2017
Materials and methods: A prospective study were patients treated with CPAP for at least 3
months, after optimizing their initial CPAP treatment will be divided into 4 groups; Group 1)
Rescue those with less than 4 h/d compliance; Group 2) Optimize compliance on those with
months, after optimizing their initial CPAP treatment will be divided into 4 groups; Group 1)
Rescue those with less than 4 h/d compliance; Group 2) Optimize compliance on those with
| | |
… of continuous positive airway pressure therapy on left ventricular diastolic function in patients with severe obstructive sleep apnea (CPAP-OASIS): a randomized …
YJ Cho, CY Shim, D Kim, S Park, CJ Lee, HJ Cho… - Sleep Medicine, 2017
Materials and methods: This 3-month, randomized, sham-controlled trial analyzed 52
patients with severe OSA. Patients were randomly assigned (1: 1) into parallel groups to
receive either CPAP or sham treatment for 3 months. The main investigator and patients
patients with severe OSA. Patients were randomly assigned (1: 1) into parallel groups to
receive either CPAP or sham treatment for 3 months. The main investigator and patients
| | |
Impact of emerging–PLMS during CPAP treatment on long term adherence
B Mwenge, D Rodenstein, J Bousata, I Rougui - Sleep Medicine, 2017
Results: 160 patients were recruited with a severe OSA.. 32.5%(52/160) patients had
emerging PLM ie that appeared after the disappearance of respiratory events. By comparing
patients with emerging-PLMs from others, we found that only the blood ferritin level was
emerging PLM ie that appeared after the disappearance of respiratory events. By comparing
patients with emerging-PLMs from others, we found that only the blood ferritin level was
| | |
Does obesity increase the risk of failure of CPAP therapy?
D Slouka, M Honnerova, J Vyskocilova, P Hosek… - Sleep Medicine, 2017
Materials and methods: A cohort of 479 patients treated by CPAP for OSAS was evaluated.
The data measured in sleep monitoring of the successfully treated group and of the group
where CPAP had failed were compared. Subsequently, the predictive abilities of the
The data measured in sleep monitoring of the successfully treated group and of the group
where CPAP had failed were compared. Subsequently, the predictive abilities of the
| | |
Insomnia index and locus of control as predictors of acceptance and compliance with CPAP
M Bultot, GB Mwenge - Sleep Medicine, 2017
Methods: 42 Patients with severe OSA (AHI> 20) 32 h/10f, 56±12 yo, BMI 33±6 kg/m 2, AHI
39.6±20 have been included. They were offered a CPAP. For patients who have accepted
CPAP, the efficacy of CPAP has been verified by a PSG. Scales of sleepiness (ESS), fatigue
39.6±20 have been included. They were offered a CPAP. For patients who have accepted
CPAP, the efficacy of CPAP has been verified by a PSG. Scales of sleepiness (ESS), fatigue
| | |
Spontaneous arousal related expiratory mouth leak during CPAP titration predict non-adherence in OSAS patients
M Mashita, S Nonoue, T Kato, Y Shigedo, K Kyotani… - Sleep Medicine, 2017
Materials and methods: Retrospective analysis was done in 106 moderate-to-severe OSAS
patients (age: 54.3±13.1 [mean±SD] years, body mass index [BMI]: 27.1±4.7 kg/m 2) who
received a full-night CPAP titration with PSG recording between 2010 and 2016. They were
patients (age: 54.3±13.1 [mean±SD] years, body mass index [BMI]: 27.1±4.7 kg/m 2) who
received a full-night CPAP titration with PSG recording between 2010 and 2016. They were
| | |
The effect of continuous positive airway pressure (CPAP) on overlapping and non-overlapping depressive symptoms in obstructive sleep apnoea (OSA) using linear …
S Nanthakumar, RS Bucks, TC Skinner, S Starkstein… - Sleep Medicine, 2017
Results: The averaged total number of SB episodes per night scored using vPSG recording
and the portable device were 61.2±13.71 and 78.1±22.3 for the SB group and those for the
control group were 24.4±11.6 and 28.2±13.5, respectively. The averaged sensitivity of the
and the portable device were 61.2±13.71 and 78.1±22.3 for the SB group and those for the
control group were 24.4±11.6 and 28.2±13.5, respectively. The averaged sensitivity of the
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου